|
Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | 9 Months Ended | 18 Months Ended | |
|---|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2012
|
|
| Operating expenses: | |||||
| Research and development | $ 1,595 | $ 404 | $ 404 | $ 3,892 | $ 5,062 |
| General and administrative | 1,525 | 370 | 780 | 5,428 | 6,882 |
| Total operating expenses | 3,120 | 774 | 1,184 | 9,320 | 11,944 |
| Loss from operations | (3,120) | (774) | (1,184) | (9,320) | (11,944) |
| Interest income | 2 | 2 | 2 | ||
| Net loss | (3,118) | (774) | (1,184) | (9,318) | (11,942) |
| Accretion of convertible preferred stock to redemption value | 101 | 101 | 101 | ||
| Net loss applicable to common stockholders | (3,118) | (875) | (1,285) | (9,318) | (12,043) |
| Net loss per share applicable to common stockholders-basic and diluted (in dollars per share) | $ (0.42) | $ (0.89) | $ (1.69) | $ (2.69) | $ (5.47) |
| Weighted average number of common shares used in net loss per share applicable to common stockholders-basic and diluted (in shares) | 7,438 | 979 | 759 | 3,460 | 2,202 |
| Comprehensive loss | $ (3,118) | $ (774) | $ (1,184) | $ (9,318) | $ (11,942) |